Cargando…

Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer

BACKGROUND AND PURPOSE: To determine if there are differences between dose to pelvic bone marrow (PBM) using intensity modulated radiotherapy (IMRT) under UK guidance versus conformal radiotherapy (CRT) per ACT II protocol and if differences translate to rates of early haematological adverse events...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Maxwell, Sabbagh, Ahmed, Muirhead, Rebecca, Durrant, Lisa, Van den Heuvel, Frank, Hawkins, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Scientific Publishers 2015
Materias:	Anal Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4678285/ https://www.ncbi.nlm.nih.gov/pubmed/26409831 http://dx.doi.org/10.1016/j.radonc.2015.09.009

Ejemplares similares

Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT)
por: Durrant, Lisa, et al.
Publicado: (2016)

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2020)

Theory of functions of a complex variable /
por: Markushevich, A. I. (Alekseĭ Ivanovich), 1908-
Publicado: (1977)

Social determinants of stage IV anal cancer and the impact of pelvic radiotherapy in the metastatic setting
por: Repka, Michael C., et al.
Publicado: (2017)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer
por: Holyoake, Daniel L.P., et al.
Publicado: (2016)

Dermatoscopy and Optical Coherence Tomography in Vulvar High-Grade Squamous Intraepithelial Lesions and Lichen Sclerosus: A Prospective Observational Trial
por: Huisman, Bertine W., et al.
Publicado: (2023)

Diarios y anales /
por: Goethe, Johann Wolfgang von, 1749-1832
Publicado: (1986)

Anales de Tecamachalco, 1398-1590
Publicado: (1992)

Asbestos exposure and haematological malignancies: a Danish cohort study
por: Würtz, Else Toft, et al.
Publicado: (2020)

IMRT, RapidArc® and conformal radiotherapy in the treatment of tumours of the anal canal
por: Cendales, Ricardo, et al.
Publicado: (2014)

Urinary adverse effects of pelvic radiotherapy
por: Liberman, Daniel, et al.
Publicado: (2014)

Carbon Ion Radiotherapy for Locally Recurrent Rectal Cancer of Patients with Prior Pelvic Irradiation
por: Yamada, Shigeru, et al.
Publicado: (2021)

Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer
por: Shao, Jun, et al.
Publicado: (2020)

Initial Results from the Royal College of Radiologists' UK National Audit of Anal Cancer Radiotherapy 2015
por: Muirhead, R., et al.
Publicado: (2017)

A nationwide longitudinal study on risk factors for progression of anal intraepithelial neoplasia grade 3 to anal cancer
por: Faber, Mette T., et al.
Publicado: (2022)

A meta‐analysis of anal cancer incidence by risk group: Toward a unified anal cancer risk scale
por: Clifford, Gary M., et al.
Publicado: (2020)

Prognostic factors for patients with anal cancer treated with conformal radiotherapy—a systematic review
por: Theophanous, Stelios, et al.
Publicado: (2022)

Breast-conserving radiotherapy with simultaneous integrated boost; field-in-field three-dimensional conformal radiotherapy versus inverse intensity-modulated radiotherapy – A dosimetric comparison: Do we need intensity-modulated radiotherapy?
por: Joseph, Bindhu, et al.
Publicado: (2018)

Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events
por: Bennett, Charles L, et al.
Publicado: (2022)

Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017)

FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma
por: Krengli, Marco, et al.
Publicado: (2010)

Comparison of four 3D conformal treatment techniques to optimise radiotherapy treatment for anal cancer
por: Cray, Alison, et al.
Publicado: (2014)

Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma
por: Bluemke, Emma, et al.
Publicado: (2020)

Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer
por: Tsuchida, Keisuke, et al.
Publicado: (2020)

Environmental scan of anal cancer screening practices: worldwide survey results
por: Patel, Jigisha, et al.
Publicado: (2014)

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022)

Association Between Bone Marrow Dosimetric Parameters and Acute Hematologic Toxicity in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy: Comparison of Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiation Therapy
por: Hui, Beina, et al.
Publicado: (2014)

Pelvic collection drainage by Heald anal stent
por: Cook, EJ, et al.
Publicado: (2012)

Increased risk of pelvic fracture after radiotherapy in rectal cancer survivors: A propensity matched study
por: Kang, Yu‐Mei, et al.
Publicado: (2019)

Stereotactic body radiotherapy for moderately central and ultra-central oligometastatic disease: Initial outcomes
por: Cooke, Rosie, et al.
Publicado: (2020)

Association between cancer‐specific adverse event triggers and mortality: A validation study
por: Weingart, Saul N., et al.
Publicado: (2020)

Comparison of three‐dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus
por: Su, Fang, et al.
Publicado: (2018)

A rigorous exploration of anal HPV genotypes using a next‐generation sequencing (NGS) approach in HIV‐infected men who have sex with men at risk for developing anal cancer
por: Piyathilake, Chandrika J., et al.
Publicado: (2019)

Patient preferences for reducing bowel adverse events following prostate radiotherapy
por: Mishra, Mark V., et al.
Publicado: (2020)

Intensity-modulated radiotherapy for synchronous cancer of the anal canal and cervix
por: Kawamoto, Terufumi, et al.
Publicado: (2018)

Signal Detection of Adverse Events Associated with Trastuzumab in a Cohort of Elderly Patients with Breast Cancer
por: Polychronopoulou, Efstathia, et al.
Publicado: (2022)

VITAL phase 2 study: Upfront 5‐fluorouracil, mitomycin‐C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09‐02)
por: Feliu, Jaime, et al.
Publicado: (2019)

Clinical Practices and Institutional Protocols on Prophylaxis, Monitoring, and Management of Selected Adverse Events Associated with Trastuzumab Deruxtecan
por: Bardia, Aditya, et al.
Publicado: (2022)

The Role of Haematological Parameters in Predicting the Response To Radical Chemoradiotherapy in Patients with Anal Squamous Cell Cancer
por: Stojanovic-Rundic, Suzana, et al.
Publicado: (2021)

Evolution of the Role of Radiotherapy for Anal Cancer
por: Dee, Edward Christopher, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t59mq4lpt3m0pan0ohdjcjp1eq